RxDoctor Payments Data

Nicole Pontee, MD

Physical Medicine & Rehabilitation · Miami, FLNPI 1619361789

Payments from drug & device makers

$978in general payments, 2019–2025

Across 20 payments — averaging $48.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$436
  • Piramal Critical Care$151
  • Merz North America, Inc.$146
  • Abbott$141
  • Merz Pharmaceuticals, LLC$45
  • Amneal Pharmaceuticals LLC$30
  • plus $29 from 1 others

What the payments were for

  • Food & beverage$978100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)9$436
Piramal Critical Care4$151
Merz North America, Inc.2$146
Abbott1$141
Merz Pharmaceuticals, LLC1$45
Amneal Pharmaceuticals LLC1$30
Medtronic2$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$978 in reported general payments places this provider in the 75th percentile of 618 physical medicine & rehabilitation providers in Florida.

See all physical medicine & rehabilitation providers in Florida

Medicare billing

Part B allowed, 2024
$54,893
Medicare patients
139
Services billed
605

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium13$369
Gabapentin18$160
Venlafaxine Hcl ErVenlafaxine Hcl11$88
Pantoprazole Sodium14$44
Hydralazine Hcl11$35

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →